Smart Diabetes Management Market Outlook, 2019-2027

Smart Diabetes Management Market (Product: Devices and Apps & Software; Application: Type 1 Diabetes and Type 2 Diabetes: End User: Self/Home Healthcare and Hospital/ Specialty Diabetes Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Smart Diabetes Management Market: Innovation to Catalyze Growth

Diabetes research and treatment has made enormous strides in the past decade.  However, the need for round-the-clock self-monitoring continues to open the door for smart technologies in diabetes management. The need for constant vigilance in terms of tracking blood sugar levels, physical exercise, and food intake warrant the shift towards smart maintenance technologies for diabetes care. With 'patient-physician connectivity', being the new catchphrase for smart diabetes management device manufacturers, the industry, in its entirety, is vying towards developing devices that wirelessly transmit diabetes readings from the patient to the diabetes care provider.

The emergence of state-of-the-art diabetes management technologies such as digital food journals for insulin administration and glucose measurement have highly eased the process of diabetes monitoring. Consumer behavior is centered on 'peace of mind' when it comes to conditions such as diabetes that have an elusive cure. The mounting need for data transmission and automation in the landscape of diabetes management has created an environment where 'digital' and 'analog' technologies coexist. This revolution in the smart diabetes management market has encouraged TMR analysts to conduct elaborate research that helps stakeholders understand the market dynamics and make data-driven business decisions.

smart diabetes managment market strategy

Transition of the Smart Devices Management Market

In the scramble towards innovation, efforts manufacturers in the smart devices management market are directed towards the development of devices offering real-time feedback about therapeutic intervention. These developments have translated into diabetes patients getting increasingly involved in their own care. Closed-loop insulin delivery is now replacing conventional vial and syringes, with 'convenience' driving consumer choice when it comes to insulin administration. Yet another transformation in consumer behavior is that, they are wary of using multiple devices for diabetes management. Resultantly, diabetes care devices equipped with multiple functions are taking center stage.

While continuous advancements in diabetes care technologies such as portable glucometers, smart tattoos, and insulin pumps transcend the market’s expansion, patient privacy and data security still remain key challenges. However, these bottlenecks may dictate the way for future innovations, and may also be banked upon by new entrants to pave their way into the global market. In 2018, the smart diabetes management market was valued at ~ US$ 3.7 Bn, and is anticipated to attain the mark of ~ US$ 13.6 Bn by the end of 2027.

Trends That are Here to Stay

The traditional ways of measuring blood glucose levels are now getting replaced by continuous glucose monitoring (CGM). Moreover, the face of insulin delivery systems has been revolutionized with insulin pumps getting upgraded to become CGM systems. Consumers are increasingly preferring devices that integrate the functions of both, insulin pumps and CGM systems. This is mainly because they are wary of using devices that require fingerstick tests, making the entire insulin or glucose monitoring process cumbersome. The emergence of tubing-free patch pumps that adhere directly to the skin has further directed the way for the penetration of new technologies and devices. Also, as these devices satiate consumer demand for the self-management of diabetes, they are expected to reap high revenue benefits for the smart diabetes management market, accounting for ~ 90% of the market share in 2018.

It is not just innovation in diabetes management devices but the digitalization of diabetes management that has created a rage in the market. Digital diabetes solutions have inundated the smart diabetes management market, thriving on the back of smart consumer devices. The increasing use of smartphones has played a pivotal role in the proliferation of 'digitalization' in the landscape of diabetes management. According to research, active users of digital diabetes sources cover around 2/3 of the world’s population. Consequently, manufacturers are building more consumer-oriented and device-agnostic digital diabetes apps.

smart diabetes managment market north america

Winning Strategies to Tackle Market Turbulence

Acquisitions and collaborations are what leading players in the smart diabetes management market rely on when it comes to establishing their base in the global market. These alliances are essentially aimed at expanding the reach in regional markets, and gaining technological strength to offer better diabetes care solutions. For instance, in January 2018, GlucoMe integrated with Apollo Sugar Clinic, based in India, which helped it expand its product portfolio and customer reach in India. Similarly, it entered into a collaboration with Merck KGaA to strengthen its digital diabetes care solutions and enhance its consumer base. Companies are also forming partnerships with leading pharmaceutical companies to develop and supply advanced diabetes care technologies and products.

With the subsequent rise in the approval rate of products, companies are concentrating their efforts towards launching new products for diabetes management, be it devices or apps. The reason for the deployment of this strategy is also attributable to the rise in consumer inclination towards innovative and easy-to-use products. In August 2016, F. Hoffmann-La Roche Ltd launched Accu-Chek Guide, a blood glucose monitoring system. Further, in June 2017 Medtronic launched the MiniMed 670G system for type 1 diabetes treatment. These launches were followed by many other new products that not only simplified diabetes management for patients and clinicians but enhanced the accuracy in results.

Competition Landscape to Remain Consolidated

The global smart diabetes management market features a highly consolidated vendor landscape, with the top three players accounting for ~ 73% of the market share in 2018. Medtronic alone accounted for ~ 43% of the market share, and is expected continue to stay high on the growth ladder throughout the forecast period. A diverse product portfolio, new product launches and approvals, and strong regional presence is what helped it attain a leading position in the market. Dexcom, Inc. accounted for ~ 22% market share, which was mainly driven by a robust distribution network coupled with new product launches. It was followed by F. Hoffmann-La Roche Ltd occupying ~ 7% market share, mainly due to a strong geographical reach and product portfolio.

Other players in the market include

  • Insulet Corporation
  • Abbott
  • Jiangsu Delfu medical device Co., Ltd
  • DIAMESCO CO., Ltd.
  • LifeScan, Inc.
  • Glooko, Inc.
  • GlucoMe.

The competitive rivalry among players is mainly characterized by soaring product approvals. For instance, in July 2018, F. Hoffmann-La Roche Ltd received the CE mark for its Accu-Chek Solo Micropump system. Similarly, in June 2018, Medtronic received approval from the U.S. Food & Drug Administration for the MiniMed 670G system for use in the treatment of type 1 diabetes in children aged seven years and above. Apart from this, increasing investments in research and development activities, strategic partnerships, and strengthening digital channels have helped some players outshine others in the market.

smart diabetes managment market segmentation

Analysts’ Viewpoint

TMR analysts’ have an optimistic outlook on the market’s future, and expect it to grow tremendously during the forecast period. With the gamut of the smart devices management industry being technology-driven, players enhancing their technological and innovation quotient will get the first-mover advantage. While the high costs of devices continues to be a key challenge in the market, it gives a significant entry point for newcomers in the market. TMR analysts also opine that, digitalization of the diabetes management industry opens up a plethora of new opportunities for market players. Focus on developing customer-friendly and device-agnostic apps will help companies garner considerable consumer attention. Overall, the rise in government support and development of diabetes care devices integrated with multiple functions will foster the market’s growth. 

  • According to Transparency Market Research’s latest market report on the smart diabetes management market for the historical period of 2017-2018 and forecast of 2019-2027, favourable reimbursements for digital diabetes management products and surge in the adoption of technologically-advanced products are key factors that are likely to boost the smart diabetes management market.
  • According to the report, the global smart diabetes management market was valued at ~ US$ 3.7 Bn in 2018. The smart diabetes management market is projected to grow at a CAGR of ~ 15% during the forecast period - 2019 to 2027.

Favorable Reimbursements for Smart Diabetes Management Products: A Key Driver

  • Smart diabetes management devices primarily include insulin delivery devices, blood glucose monitoring devices and apps, and software to track and integrate the data collected through these devices for better diabetes management.
  • The U.S. Medicare and Medicaid and other regional payer agencies provide reimbursements for digital diabetes management products for the treatment of type 1 and type 2 diabetes.
  • In September 2017, Abbott received approval for the FreeStyle Libre system from the National Health Service (NHS) for diabetes management. This approval enabled the product to be covered under reimbursement across Wales and England.
  • In July 2017, DarioHealth Corp entered into a partnership agreement with Byram Healthcare. This agreement enabled the company to expand insurance health coverage for digital diabetes management products for U. S. consumers.
  • Private insurance policies also provide reimbursements for smart diabetes management products.

New Product Development and Technological Advancements

  • Key market players engage in the development of technologically-advanced products for smart diabetes management.
  • The rising demand for smart diabetes management products due to a surge in the adoption of technological advancements is anticipated to drive the smart diabetes management market.
  • For instance, the insulin patch is a technological advancement for the insulin delivery system. F. Hoffmann-La Roche Ltd. offers the insulin patch pump for insulin delivery. It is a semi-disposable patch with reusable components.
  • iLet, offered by Beta Bionics, is an automated insulin delivery system. iLet’s integrated technology is a combination of Senseonic’s Eversense CGM and iLet bionic pancreas.
  • iSenz, offered by inGageIT Digital Health, is specially offered for patients who have insulin-dependent diabetes. It automatically tracks and updates the dose. Additionally, it possesses a monitoring system for noninvasive injections.
  • Eversense CGM System, a long-term CGM system offered by Senseonics, Inc., contains an implantable sensor, convenient app, and rechargeable and removable transmitter in order to monitor and manage diabetes for up to 3 months.

High Cost of Products Restrains the Smart Diabetes Management Market

  • Cost is a major factor hampering the selection of treatment.
  • The cost of smart diabetes management products is a barrier in the treatment of type 1 and type 2 diabetes.
  • The cost of smart diabetes management products is higher than traditional diabetes management products. For instance, Dexcom G5/G6 transmitter cost around US$ 300, Medtronic Guardian Connect cost per sensor is US$ 80.
  • According to an article published in AJMC, the estimated cost of an insulin infusion pump per person is around US$ 4,500, with additional cost of supplies exceeding US$ 1,500 per year.

Smart Diabetes Management Market: Competition Landscape

  • This report profiles major players in the global smart diabetes management market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.
  • The smart diabetes management market is moderately fragmented, with the presence of a few large-scale players present in international markets and numerous small-scale players in regional markets. The top 3 to 4 key players hold a major share of the global smart diabetes management market.
  • Prominent players operating in the smart diabetes management market include
    • F. Hoffmann-La Roche Ltd
    • Medtronic
    • Dexcom, Inc.
    • Insulet Corporation
    • Abbott
    • Jiangsu Delfu medical device Co., Ltd
    • DIAMESCO CO., Ltd.
    • LifeScan, Inc.
    • Glooko, Inc.
    • GlucoMe.

Smart Diabetes Management Market: Key Developments

Key players in the smart diabetes management market engage in the development of new products, key mergers & acquisitions, collaborations, and integration. Key developments by industry players are likely to fuel the smart diabetes management market. Some developments in the smart diabetes management market are as follows:

  • In February 2019, Dexcom, Inc. received approval from Health Canada for the Dexcom G6 CGM system for the treatment of diabetes in patients of ages 2 years and above. This product approval enabled the company to build capacity in order to support global launch plans and enhance its product portfolio for diabetes management.
  • In March 2019, DarioHealth entered into marketing agreement with Glytec for diabetes management. This agreement enabled the company to strengthen its customer reach.
  • In December 2017, Companion Medical launched the InPen in the U.S. This product launch enabled the company to strengthen its diabetes management portfolio in the U.S.

In the global smart diabetes management market report, we have discussed individual strategies, followed by company profiles of the manufacturers of smart diabetes management devices and apps & software. The ‘Competitive Landscape’ section is included in the smart diabetes management market report to provide readers with a dashboard view and a company market share analysis of the key players operating in the global smart diabetes management market.

Smart Diabetes Management Market: Taxonomy

The study on the smart diabetes management market segments it into four broad categories - product, application, end user, and region. Each segment has been analyzed in detail to understand the key segment-specific trends and growth opportunities. Prominent factors instrumental in the growth or descend of each segment in the smart diabetes management market have been highlighted.

Product

Devices

  • Smart Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Smart Insulin Pens
  • Smart Insulin Pumps
  • Closed Loop Systems

Apps and Software

Application

Type 1 Diabetes

Type 2 Diabetes

End User

Self/Home Healthcare

Hospital/Specialty/Diabetes Clinics

Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Frequently Asked Questions

What is the total market worth of smart diabetes management market?

The global smart diabetes management market was worth US$ 3.7 Bn and is projected to reach a value of US$ 13.6 Bn by the end of 2027

What is the anticipated CAGR of the smart diabetes management market in the forecast period?

Smart diabetes management market is anticipated to grow at a CAGR of 15% during the forecast period

Which region is expected to project the highest market share in the global smart diabetes management market?

North America accounted for a major share of the global smart diabetes management market

What are the key driving factors for the growth of the smart diabetes management market?

Smart Diabetes Management Market is driven by favourable reimbursements for digital diabetes management products and surge in the adoption of technologically-advanced products

Who are the key players in the global smart diabetes management market?

Key players in the global smart diabetes management market include F. Hoffmann-La Roche Ltd, Medtronic, Dexcom, Inc., Insulet Corporation, Abbott, Jiangsu Delfu medical device Co., Ltd, DIAMESCO CO., Ltd., LifeScan, Inc., Glooko, Inc., and GlucoMe

    1. Preface
        1.1. Market Definition and Scope
        1.2. Market Segmentation
        1.3. Key Research Objectives
        1.4. Research Highlights
    2. Assumptions and Research Methodology
    3. Executive Summary: Global Smart Diabetes Management Market 
    4. Market Overview

        4.1. Introduction
            4.1.1. Products Definition
            4.1.2. Industry Evolution / Developments
        4.2. Overview
        4.3. Market Dynamics
            4.3.1. Drivers
                4.3.1.1. Rise in prevalence of diabetes
                4.3.1.2. Increase in awareness about diabetes
                4.3.1.3. Favourable reimbursement policies
                4.3.1.4. Surge in adoption of connected medical devices
            4.3.2. Restraints
                4.3.2.1. High cost
                4.3.2.2. Patient and provider burden
                4.3.2.3. Patient privacy & data security
            4.3.3. Opportunities
        4.4. Global Smart Diabetes Management Market Analysis and Forecast, 2019–2027
    5. Market Outlook
        5.1. Technological Advancement
        5.2. Key Development (Product launch, Approval, Collaboration, Partnership, and Acquisitions)
        5.3. Diabetes Prevalence in Key Countries 
    6. Global Smart Diabetes Management Market Analysis and Forecast, By Products 
        6.1. Introduction & Definition
        6.2. Key Findings / Developments
        6.3. Global Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
            6.3.1. Devices 
                6.3.1.1. Smart Glucose Meters
                6.3.1.2. Continuous Glucose Monitoring Systems
                6.3.1.3. Smart Insulin Pens
                6.3.1.4. Smart Insulin Pumps
                6.3.1.5. Closed Loop Systems
            6.3.2. Apps & Software
        6.4. Global Smart Diabetes Management Market Attractiveness, by Product 
    7. Global Smart Diabetes Management Market Analysis and Forecast, by Application 
        7.1. Introduction & Definition
        7.2. Key Findings / Developments
        7.3. Global Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
            7.3.1. Type 1 Diabetes 
            7.3.2. Type 2 Diabetes 
        7.4. Global Smart Diabetes Management Market Attractiveness, by Application 
    8. Global Smart Diabetes Management Market Analysis and Forecast, by End-user 
        8.1. Introduction & Definition
        8.2. Key Findings / Developments
        8.3. Global Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
            8.3.1. Self/Home Healthcare
            8.3.2. Hospital/Specialty Diabetes Clinics
        8.4. Global Smart Diabetes Management Market Attractiveness, by End-user 
    9. Global Smart Diabetes Management Market Analysis and Forecast, by Region
        9.1. Key Findings
        9.2. Global Smart Diabetes Management Market Value Forecast, by Region
            9.2.1. North America 
            9.2.2. Europe 
            9.2.3. Asia Pacific 
            9.2.4. Latin America 
            9.2.5. Middle East & Africa 
        9.3. Global Smart Diabetes Management Market Attractiveness, by Region
    10. North America Smart Diabetes Management Market Analysis and Forecast
        10.1. Introduction
            10.1.1. Key Findings
        10.2. North America Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
            10.2.1. Devices 
                10.2.1.1. Smart Glucose Meters
                10.2.1.2. Continuous Glucose Monitoring Systems
                10.2.1.3. Smart Insulin Pens
                10.2.1.4. Smart Insulin Pumps
                10.2.1.5. Closed Loop Systems
            10.2.2. Apps & Software
        10.3. North America Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
            10.3.1. Type 1 Diabetes 
            10.3.2. Type 2 Diabetes 
        10.4. North America Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
            10.4.1. Self/Home Healthcare
            10.4.2. Hospital/Specialty Diabetes Clinics
        10.5. North America Smart Diabetes Management Market Value Forecast, by Country, 2019–2027
            10.5.1. U.S.
            10.5.2. Canada
        10.6. North America Smart Diabetes Management Market Attractiveness Analysis 
            10.6.1. By Products 
            10.6.2. By Application 
            10.6.3. By End-user 
            10.6.4. By Country
    11. Europe Smart Diabetes Management Market Analysis and Forecast
        11.1. Introduction
            11.1.1. Key Findings
        11.2. Europe Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
            11.2.1. Devices 
                11.2.1.1. Smart Glucose Meters
                11.2.1.2. Continuous Glucose Monitoring Systems
                11.2.1.3. Smart Insulin Pens
                11.2.1.4. Smart Insulin Pumps
                11.2.1.5. Closed Loop Systems
            11.2.2. Apps & Software
        11.3. Europe Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
            11.3.1. Type 1 Diabetes 
            11.3.2. Type 2 Diabetes 
        11.4. Europe Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
            11.4.1. Self/Home Healthcare
            11.4.2. Hospital/Specialty Diabetes Clinics
        11.5. Europe Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
            11.5.1. Germany
            11.5.2. U.K.
            11.5.3. France
            11.5.4. Spain
            11.5.5. Italy
            11.5.6. Rest of Europe
        11.6. Europe Smart Diabetes Management Market Attractiveness Analysis 
            11.6.1. By Products 
            11.6.2. By Application 
            11.6.3. By End-user 
            11.6.4. By Country/Sub-region
    12. Asia Pacific Smart Diabetes Management Market Analysis and Forecast
        12.1. Introduction
            12.1.1. Key Findings
        12.2. Asia Pacific Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
            12.2.1. Devices 
                12.2.1.1. Smart Glucose Meters
                12.2.1.2. Continuous Glucose Monitoring Systems
                12.2.1.3. Smart Insulin Pens
                12.2.1.4. Smart Insulin Pumps
                12.2.1.5. Closed Loop Systems
            12.2.2. Apps & Software
        12.3. Asia Pacific Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
            12.3.1. Type 1 Diabetes 
            12.3.2. Type 2 Diabetes 
        12.4. Asia Pacific Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
            12.4.1. Self/Home Healthcare
            12.4.2. Hospital/Specialty Diabetes Clinics
        12.5. Asia Pacific Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
            12.5.1. China
            12.5.2. Japan
            12.5.3. India
            12.5.4. Australia & New Zealand
            12.5.5. Rest of Asia Pacific
        12.6. Asia Pacific Smart Diabetes Management Market Attractiveness Analysis 
            12.6.1. By Products 
            12.6.2. By Application 
            12.6.3. By End-user 
            12.6.4. By Country/Sub-region
    13. Latin America Smart Diabetes Management Market Analysis and Forecast
        13.1. Introduction
            13.1.1. Key Findings
        13.2. Latin America Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
            13.2.1. Devices 
                13.2.1.1. Smart Glucose Meters
                13.2.1.2. Continuous Glucose Monitoring Systems
                13.2.1.3. Smart Insulin Pens
                13.2.1.4. Smart Insulin Pumps
                13.2.1.5. Closed Loop Systems
            13.2.2. Apps & Software
        13.3. Latin America Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
            13.3.1. Type 1 Diabetes 
            13.3.2. Type 2 Diabetes 
        13.4. Latin America Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
            13.4.1. Self/Home Healthcare
            13.4.2. Hospital/Specialty Diabetes Clinics
        13.5. Latin America Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
            13.5.1. Brazil
            13.5.2. Mexico
            13.5.3. Rest of Latin America
        13.6. Latin America Smart Diabetes Management Market Attractiveness Analysis 
            13.6.1. By Product 
            13.6.2. By Application 
            13.6.3. By End-user 
            13.6.4. By Country/Sub-region
    14. Middle East & Africa Smart Diabetes Management Market Analysis and Forecast
        14.1. Introduction
            14.1.1. Key Findings
        14.2. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
            14.2.1. Devices 
                14.2.1.1. Smart Glucose Meters
                14.2.1.2. Continuous Glucose Monitoring Systems
                14.2.1.3. Smart Insulin Pens
                14.2.1.4. Smart Insulin Pumps
                14.2.1.5. Closed Loop Systems
            14.2.2. Apps & Software
        14.3. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
            14.3.1. Type 1 Diabetes 
            14.3.2. Type 2 Diabetes 
        14.4. Middle East & Africa Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
            14.4.1. Self/Home Healthcare
            14.4.2. Hospital/Specialty Diabetes Clinics
        14.5. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
            14.5.1. GCC Countries
            14.5.2. South Africa
            14.5.3. Rest of Middle East & Africa
        14.6. Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis 
            14.6.1. By Products 
            14.6.2. By Application 
            14.6.3. By End-user 
            14.6.4. By Country/Sub-region
    15. Competition Landscape
        15.1. Market Player – Competition Matrix (By Tier and Size of companies)
        15.2. Market Share Analysis By Company (2018)
        15.3. Company Profiles
            15.3.1. F. Hoffmann-La Roche Ltd 
                15.3.1.1. Company Overview
                15.3.1.2. Product Portfolio
                15.3.1.3. SWOT Analysis
                15.3.1.4. Financial Overview
                15.3.1.5. Strategic Overview
            15.3.2. Medtronic
                15.3.2.1. Company Overview
                15.3.2.2. Product Portfolio
                15.3.2.3. SWOT Analysis
                15.3.2.4. Financial Overview
                15.3.2.5. Strategic Overview
            15.3.3. Dexcom, Inc
                15.3.3.1. Company Overview
                15.3.3.2. Product Portfolio
                15.3.3.3. SWOT Analysis
                15.3.3.4. Financial Overview
                15.3.3.5. Strategic Overview
            15.3.4. Insulet Corporation 
                15.3.4.1. Company Overview
                15.3.4.2. Product Portfolio
                15.3.4.3. SWOT Analysis
                15.3.4.4. Financial Overview
                15.3.4.5. Strategic Overview
            15.3.5. Abbott
                15.3.5.1. Company Overview
                15.3.5.2. Product Portfolio
                15.3.5.3. SWOT Analysis
                15.3.5.4. Financial Overview
                15.3.5.5. Strategic Overview
            15.3.6. Jiangsu Delfu medical device Co., Ltd 
                15.3.6.1. Company Overview
                15.3.6.2. Product Portfolio
                15.3.6.3. SWOT Analysis
            15.3.7. DIAMESCO CO., Ltd.
                15.3.7.1. Company Overview
                15.3.7.2. Product Portfolio
                15.3.7.3. SWOT Analysis
            15.3.8. LifeScan, Inc. 
                15.3.8.1. Company Overview
                15.3.8.2. Product Portfolio
                15.3.8.3. SWOT Analysis
                15.3.8.4. Strategic Overview
            15.3.9. Glooko, Inc.
                15.3.9.1. Company Overview
                15.3.9.2. Product Portfolio
                15.3.9.3. SWOT Analysis
                15.3.9.4. Strategic Overview
            15.3.10. GlucoMe
                15.3.10.1. Company Overview
                15.3.10.2. Product Portfolio
                15.3.10.3. SWOT Analysis
                15.3.10.4. Strategic Overview

    List of Tables

    Table 01: New Product Launch & FDA Approvals
    Table 02: New Product Launch & FDA Approvals
    Table 03: New Product Launch & FDA Approvals
    Table 04: Key Development (Collaboration, Partnership, Merger & Acquisition)
    Table 05: Key Development (Collaboration, Partnership, Merger & Acquisition)
    Table 06: Diabetes Prevalence in Key Countries 
    Table 07: Diabetes Prevalence in Key Countries
    Table 08: Diabetes Prevalence in Key Countries
    Table 09: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
    Table 10: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
    Table 11: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
    Table 12: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
    Table 13: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Region, 2017–2027
    Table 14: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
    Table 15: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
    Table 16: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
    Table 17: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
    Table 18: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country, 2017–2027
    Table 19: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
    Table 20: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
    Table 21: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
    Table 22: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
    Table 23: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
    Table 24: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
    Table 25: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
    Table 26: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
    Table 27: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
    Table 28: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
    Table 29: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
    Table 30: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
    Table 31: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
    Table 32: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
    Table 33: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
    Table 34: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
    Table 35: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
    Table 36: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
    Table 37: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
    Table 38: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    List of Figures

    Figure 01: Global Smart Diabetes Management Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
    Figure 02: Global Smart Diabetes Management Market Value (US$ Mn), by Product, 2018
    Figure 03: Market Snapshot - Top 2 Trends
    Figure 04: Market Overview
    Figure 05: Global Smart Diabetes Management Market Value Share, by Product, 2018
    Figure 06: Global Smart Diabetes Management Market Value Share, by Application, 2018
    Figure 07: Global Smart Diabetes Management Value Share, by End-user, 2018
    Figure 08: Global Smart Diabetes Management Market Value Share, by Region, 2018
    Figure 09: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, 2017–2027
    Figure 10: Global Smart Diabetes Management Market Share Analysis, by Product, 2018 and 2027
    Figure 11: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Devices, 2017–2027
    Figure 12: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Apps & Software, 2017–2027
    Figure 13: Global Smart Diabetes Management Market Attractiveness Analysis, by Product, 2018–2026
    Figure 14: Global Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
    Figure 15: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Type 1 Diabetes, 2017–2027
    Figure 16: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Type 2 Diabetes, 2017–2027
    Figure 17: Global Smart Diabetes Management Market Attractiveness Analysis, by Application, 2018–2026
    Figure 18: Global Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
    Figure 19: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Self/Home Healthcare, 2017–2027
    Figure 20: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Hospital/Specialty Diabetes Clinics, 2017–2027
    Figure 21: Global Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2018–2027
    Figure 22: Global Smart Diabetes Management Market Value Share Analysis, by Region, 2018 and 2027
    Figure 23: Global Smart Diabetes Management Market Attractiveness Analysis, by Region, 2018–2026
    Figure 24: North America Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
    Figure 25: North America Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
    Figure 26: North America Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
    Figure 27: North America Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
    Figure 28: North America Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
    Figure 29: North America Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
    Figure 30: North America Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
    Figure 31: North America Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
    Figure 32: North America Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
    Figure 33: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
    Figure 34: Europe Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
    Figure 35: Europe Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
    Figure 36: Europe Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
    Figure 37: Europe Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
    Figure 38: Europe Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
    Figure 39: Europe Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
    Figure 40: Europe Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
    Figure 41: Europe Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
    Figure 42: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
    Figure 43: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
    Figure 44: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
    Figure 45: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
    Figure 46: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
    Figure 47: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
    Figure 48: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
    Figure 49: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
    Figure 50: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
    Figure 51: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
    Figure 52: Latin America Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
    Figure 53: Latin America Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
    Figure 54: Latin America Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
    Figure 55: Latin America Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
    Figure 56: Latin America Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
    Figure 57: Latin America Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
    Figure 58: Latin America Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
    Figure 59: Latin America Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
    Figure 60: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
    Figure 61: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
    Figure 62: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
    Figure 63: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
    Figure 64: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
    Figure 65: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
    Figure 66: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
    Figure 67: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
    Figure 68: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
    Figure 69: F. Hoffmann-La Roche Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
    Figure 70: F. Hoffmann-La Roche Ltd Breakdown of Net Sales (%) of Diabetes Care Sub-segment, by Region, 2018
    Figure 71: F. Hoffmann-La Roche Ltd Breakdown of Net Sales (%), by Diagnostics Division, 2018
    Figure 72: F. Hoffmann-La Roche Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
    Figure 73: Medtronic Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
    Figure 74: Medtronic Breakdown of Net Sales (%), by Geography, 2018
    Figure 75: Medtronic Breakdown of Net Sales (%), by Business Segment, 2018
    Figure 76: Medtronic R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
    Figure 77: Dexcom, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
    Figure 78: Dexcom, Inc. Breakdown of Net Sales (%), by Geography, 2017
    Figure 79: Dexcom, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
    Figure 80: Insulet Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
    Figure 81: Insulet Corporation Breakdown of Net Sales (%), by Geography, 2017
    Figure 82: Insulet Corporation Breakdown of Net Sales (%), by Business Segment, 2017
    Figure 83: Insulet Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
    Figure 84: Abbott Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
    Figure 85: Abbott Breakdown of Net Sales (%), by Country, 2018
    Figure 86: Abbott Breakdown of Net Sales (%), by Business Segment, 2018
    Figure 87: Abbott R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Copyright © Transparency Market Research, Inc. All Rights reserved